SecurityPSCI / PowerShares Exchange-Traded Fund Trust II (73937B878)
Institutional Owners37 (1 N-Q Owners)
Institutional Shares1,146,285 (ex. N-Q)
Institutional Value$ 73,952,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

PowerShares Exchange-Traded Fund Trust II (NASDAQ:PSCI) has 37 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,146,285 shares. Largest shareholders include Wells Fargo & Company/mn, Bank Of America Corp /de/, Morgan Stanley, Northern Capital Management Llc, Karp Capital Management Corp, Raymond James & Associates, Susquehanna International Group, Llp, Fis Group, Inc., UBS Group AG, and Royal Bank Of Canada.
PowerShares Exchange-Traded Fund Trust II (NASDAQ:PSCI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-18 13F-HR CIBC World Markets Inc. 0 6,493 0 419
2018-02-14 13F-HR/A PUTNAM INVESTMENTS LLC 38,892 0 -100.00 2,370 0 -100.00
2018-05-15 13F-HR JANE STREET GROUP, LLC 12,414 0 -100.00 801 0 -100.00
2018-05-11 13F-HR SevenBridge Financial Group, LLC 293 0 -100.00 19 0 -100.00
2018-05-15 13F-HR Spectrum Financial Alliance Ltd Llc 52 3
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 50,794 43,070 -15.21 3,277 2,779 -15.20
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 670,086 631,075 -5.82 43,227 40,715 -5.81
2018-05-04 13F-HR Whitnell & Co. 125 8
2018-05-03 13F-HR WRAPMANAGER INC 8,609 8,538 -0.82 555 551 -0.72
2018-05-17 13F-HR Atlantic Trust Group, LLC 600 450 -25.00 39 29 -25.64
2018-05-14 13F-HR Baird Financial Group, Inc. 23,922 0 -100.00 1,543 0 -100.00
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 5,958 5,984 0.44 384 386 0.52
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 209 156 -25.36 13 10 -23.08
2018-04-23 13F-HR Advisory Services Network, LLC 7,603 8,493 11.71 490 548 11.84
2018-05-02 13F-HR FTB Advisors, Inc. 90 420 366.67 5 27 440.00
2018-04-16 13F-HR SOLARIS ASSET MANAGEMENT LLC 455 0 -100.00 29 0 -100.00
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 349 349 0.00 23 23 0.00
2018-04-11 13F-HR Country Club Trust Company, n.a. 17,245 4,515 -73.82 1,112 291 -73.83
2018-04-30 13F-HR Dorsey Wright & Associates 4,896 0 -100.00 317 0 -100.00
2018-05-15 13F-HR UBS Group AG 18,122 18,906 4.33 1,169 1,220 4.36
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 4,325 22,779 426.68 279 1,469 426.52
2018-05-08 13F-HR Karp Capital Management Corp 55,154 53,780 -2.49 3,558 3,470 -2.47
2018-05-01 13F-HR Hanson McClain, Inc. 145 145 0.00 9 9 0.00
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 191 0 -100.00 12 0 -100.00
2018-04-06 13F-HR Carroll Financial Associates, Inc. 69 69 0.00 4 4 0.00
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 193 193 0.00 12 12 0.00
2018-05-07 13F-HR GREAT LAKES ADVISORS, LLC 4,300 0 -100.00 277 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 108,076 111,568 3.23 6,972 7,198 3.24
2018-05-14 13F-HR IHT Wealth Management, LLC 308 308 0.00 20 19 -5.00
2018-05-15 13F-HR BARCLAYS PLC 62 62 0.00 4 4 0.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 103,049 119,537 16.00 6,648 7,712 16.00
2018-05-08 13F-HR US BANCORP \DE\ 2,000 2,000 0.00 129 129 0.00
2018-05-03 13F-HR Newfound Research LLC 265 266 0.38 17 17 0.00
2018-05-09 13F-HR IFP Advisors, Inc 310 1,182 281.29 20 76 280.00
2018-04-26 13F-HR FIS GROUP, INC. 26,303 21,101 -19.78 1,741 1,361 -21.83
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 0 147 0 9
2018-05-11 13F-HR SEI INVESTMENTS CO 218 0 -100.00 14 0 -100.00
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-05-04 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 164 554 237.80 11 36 227.27
2018-05-09 13F-HR OPTIMUM INVESTMENT ADVISORS 0 74 0 5
2018-05-15 13F-HR Advisor Group, Inc. 307 455 48.21 20 30 50.00
2018-05-08 13F-HR NORTHERN CAPITAL MANAGEMENT LLC 58,505 69,465 18.73 3,774 4,482 18.76
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 10,429 9,710 -6.89 673 626 -6.98
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 4,030 3,950 -1.99 260 255 -1.92
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 213 313 46.95 14 20 42.86
2018-03-29 N-Q Powershares Exchange-traded Fund Trust Ii (see advisory)

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( PSCI / PowerShares Exchange-Traded Fund Trust II ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 73937B878